Today: 9 June 2026
Schwab stock slips as Fed minutes put rate outlook back in focus

Schwab stock slips as Fed minutes put rate outlook back in focus

NEW YORK, December 30, 2025, 14:00 ET — Regular session

The Charles Schwab Corp’s shares were down 0.6% at $100.69 in afternoon trading on Tuesday, after opening at $101.58 and trading between $100.34 and $101.60. The broader market was little changed, while rivals Interactive Brokers and Robinhood also traded lower.

The move matters because Schwab earns a large share of its revenue from client cash, making the stock sensitive to shifts in interest-rate expectations. That sensitivity can show up quickly on quiet days, when small changes in rate bets have an outsized impact on financial stocks.

Investors are also looking to Federal Reserve minutes due later Tuesday for clues on the policy path after the central bank’s Dec. 9-10 meeting, as U.S. stocks trade in holiday-thin conditions near the end of the year, according to Reuters.

“The meeting minutes will likely show a range of opinions about the outlook for Fed policy,” said Cooper Howard, director of fixed income research and strategy at the Schwab Center for Financial Research. Howard said he still expects the Fed to move slowly and sees “one or two” additional cuts next year. Schwab Brokerage

For Schwab, lower rates can squeeze net interest income — the gap between what it earns on investments funded by client cash and what it pays out. Investors have also tracked “cash sorting,” when clients shift idle cash into higher-yielding products, which can change what the firm earns on those balances.

Against that backdrop, traders in Schwab tend to focus on any signal that alters the expected pace of easing in 2026, along with signs of how quickly clients move cash across sweep accounts, bank deposits and money market funds.

Separately, a Form 4 filed with the U.S. Securities and Exchange Commission on Dec. 29 showed Jonathan Beatty, managing director and head of advisor services, exercised options for 2,000 shares and a related trust sold 2,000 shares at a weighted-average price of about $102.01. The filing said the sale was made under a Rule 10b5-1 plan — a pre-arranged program that can automate trades.

Looking ahead, Schwab’s investor relations calendar lists its fourth-quarter results and December monthly activity report for the week of Jan. 19, 2026, with Jan. 21 flagged as the anticipated release date. The company also lists a Winter Business Update on Jan. 21.

Those updates will sharpen the focus on net new assets, client cash trends and expense control — key swing factors for 2026 earnings as interest rates turn. Any commentary on net interest income and balance-sheet funding will likely set the tone for how investors price the stock after the holiday lull.

For now, Schwab’s next push is likely to come from the Fed minutes later Tuesday and the market’s reading of how quickly — and how far — policymakers intend to cut rates next year.

Stock Market Today

  • Stocks Drop as Tech Weighs on Market; Oil Slides on Iran Deal Optimism
    June 9, 2026, 12:47 PM EDT. The Dow Jones Industrial Average fell 270 points, with the Nasdaq Composite dropping 2.5% amid a broad tech sector sell-off. The S&P 500 declined 0.3%, reflecting growing market caution. Oil prices also fell after former President Donald Trump suggested an Iran nuclear deal could be finalized in 'two or three days,' fueling hopes of easing geopolitical tensions. This shift dampened risk appetite, pulling major indices lower in mid-morning trading, according to FactSet data.

Latest articles

BlackBerry Shares Stall After QNX Push

BlackBerry Shares Slip Ahead of Results — What’s Moving BB Today

9 June 2026
BlackBerry’s U.S. shares plunged 8.5% to $8.50 as investors braced for the June 25 earnings report, with focus on whether the company can meet its bullish Q1 revenue forecast of $132–$140 million, well above analysts’ estimates, after QNX’s 20% revenue jump and $950 million royalty backlog last quarter.
Chip Selloff Trips Up Wall Street’s AI Rally

Chip Selloff Trips Up Wall Street’s AI Rally

9 June 2026
Nasdaq and S&P 500 tumbled midday, erasing early chip-stock gains as tech shares slid; Philadelphia Semiconductor Index dropped 2% after jumping 3%, with Broadcom, Micron, and Nvidia under pressure. Investors await key inflation data Wednesday and SpaceX’s massive IPO, both seen as catalysts for further volatility amid concerns that high valuations in AI and tech could face profit-taking if rate fears persist.
Nintendo and Sanrio Stocks Get New AI Boost

Nintendo and Sanrio Stocks Get New AI Boost

9 June 2026
Nintendo hikes Switch 2 prices in Japan and the US, citing higher memory costs and tariffs expected to add 100 billion yen to annual expenses; investors now question whether Japan’s top entertainment brands like Nintendo and Sanrio can maintain valuations as AI-driven capital shifts toward chips and automation, pressuring stock selection even as the Nikkei rebounds 2.17% after Monday’s sharp drop.
Costco Drops Kirkland Prices While Prepping New Florida Warehouse

Costco Drops Kirkland Prices While Prepping New Florida Warehouse

9 June 2026
Costco slashed prices on select Kirkland Signature products by up to $10 as part of its strategy to boost membership renewals, but shares barely moved, last at $973.50, down $1.25, after Q3 net sales rose 11.6% to $69.15 billion and net income hit $2.19 billion; management emphasized the cuts are strategic, not a chainwide rollback, amid slowing paid membership growth and ongoing competitive pressure.
Paranovus Stock Rockets 620% as $195 Million Share-Sale Filing Changes the Story

Paranovus Stock Rockets 620% as $195 Million Share-Sale Filing Changes the Story

9 June 2026
Paranovus Entertainment shares soared 620% to $6.76 after filing to potentially sell up to $195 million in new stock—an amount far exceeding its $7.14 million market cap—raising major dilution risks for investors as the company eyes acquisitions but warns that future share sales could pressure the stock price or threaten operations.
SELLAS Life Sciences (SLS) stock jumps on Phase 3 AML trial timing update — what investors watch next
Previous Story

SELLAS Life Sciences (SLS) stock jumps on Phase 3 AML trial timing update — what investors watch next

Newmont stock rebounds as gold steadies after CME margin jolt; Raymond James lifts target
Next Story

Newmont stock rebounds as gold steadies after CME margin jolt; Raymond James lifts target

Go toTop